OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Medicine is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Molecular profiling of colorectal cancer in a genetically admixed Hispanic population	387
Racial and ethnic disparities in mortality among World Trade Center Health Registry enrollees with post‐9/11 cancer	225
Issue Information	148
Effects of FABP5 Expression on Clinicopathological and Survival Characteristics in Digestive System Malignancies: A Systematic Review and Meta‐Analysis	116
Impact of Body Image Perception on Behavioral Outcomes in Chinese Adolescent and Young Adult Survivors of Sarcoma	113
Issue Information	109
Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation	96
Physical Activity Patterns According to Demographic, Social, and Clinical Correlates Among Breast Cancer Survivors	95
Oil blotting paper for formalin fixation increases endoscopic ultrasound‐guided tissue acquisition‐collected sample volumes on glass slides	91
Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma	85
	81
Intake of polyphenols from cereal foods and colorectal cancer risk in the Melbourne Collaborative Cohort Study	81
Reasoning and causal inference regarding surgical options for patients with low‐grade gliomas using machine learning: A SEER‐based study	72
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion	72
Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis	71
Cancer and the family: Variations by sex and race/ethnicity	71
Deficiency of SR‐B1 reduced the tumor load of colitis‐induced or APC^min^/+‐induced colorectal cancer	65
Inflammatory geriatric nutritional risk index stratified the survival of older adults with cancer sarcopenia	63
Association of various RAS codon mutations and prognostic outcomes of patients with colorectal liver metastases after hepatectomy	58
Physical activity, polygenic risk score, and colorectal cancer risk	57
Distinct Clinicopathological Features of HER2 ‐Negative, HER2 ‐Low, and H	57
Impact of COVID ‐19 on Time to Treat Breast Cancer and Racial Disparities Among Women in the Military Health System From FY2	56
Effect modification of age and hypertension on cancer and prevalence of self‐reported stroke – A cross‐sectional study	55
The effect of body mass index on quality of life in modified single stoma cutaneous ureterostomy or ileal conduit after radical cystectomy	54
Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer	54

Cost‐effectiveness analysis of tumor‐infiltrating lymphocytes biomarkers guiding chemotherapy de‐escalation in early triple‐negative breast cancer	53
Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy	50
Associations among navigational support and health care utilization and costs in patients with advanced cancer: An analysis based on administrative health insurance data	48
Family physicians' involvement in palliative cancer care	47
Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index	46
Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy	45
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)	45
Explorative Detection of Fractional Exhaled Nitric Oxide ( FeNO ) in Exhaled Breath of Patients With Breast Cancer	44
Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis	44
Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A Nation	44
Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database	44
Social Determinants of Health Predict Sleep–Wake Disturbances Among Patients Living With Primary Brain Tumors: A Cross‐Sectional Analysis	44
Predicting Caregiver Anxiety and Depression From Patient Distress in Brain Tumor Dyads: Actor‐Partner Interdependence Model	43
Up‐regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy	43
MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements	42
Impact of race/ethnicity and language preferences on pediatric ALL survival outcomes	42
Impact of the COVID‐19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race	42
Efficacy of fusion imaging for immediate post‐ablation assessment of malignant liver neoplasms: A systematic review	42